Fate of Bradykinin-potentiating Peptide 9a After Intravenous Injection

Overview

Journal Biochem J

Specialty Biochemistry

Date 1979 Dec 15

PMID 540061

Authors

L C Martin

J W Ryan

G H Fisher

A Chung

M Epstein

J M Stewart

Affiliations

Soon will be listed here.

Abstract

The fat of less than Glu1-3H-labelled bradykinin-potentiating peptide 9a [BPP9a; less than Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro, an inhibitor of angiotensin-converting enzyme (peptidyl dipeptidase)] was studied in the rabbit. After intravenous injection, BPP9a was rapidly removed from blood and much of the associated radioactivity was excreted in urine. Approx. 8% of the radioactivity in urine collected 2h after drug administration occurred in the form of BPP9a itself, the remainder occurring in three lower homologues: less than Glu-Trp (60%), less Glu-Trp-Pro-Arg-Pro-Gln (20%) and less than Glu-Trp-Pro-Arg-Pro-Gln-Ile (12%). Hydrolysis was not accounted for by enzymes in blood or urine. Apparently hydrolysis occurred within the kidney, as less than Gl-Trp was obtained in 60% yield in urine of isolated rat kidney perfused with [less than Glu1-3H]BPP9a.

References

Ross B, KREBS H . Metabolic activities of the isolated perfused rat kidney. Biochem J. 1967; 103(3):852-62. PMC: 1270491. DOI: 10.1042/bj1030852. View

SZEWCZUK A, Kwiatkowska J . Pyrrolidonyl peptidase in animal, plant and human tissues. Occurrence and some properties of the enzyme. Eur J Biochem. 1970; 15(1):92-6. DOI: 10.1111/j.1432-1033.1970.tb00980.x. View

Ryan J, Roblero J, Stewart J, Leary W . Metabolism of vasoactive polypeptides in the pulmonary circulation. Chest. 1971; 59:Suppl:8S-9S. DOI: 10.1378/chest.59.5_supplement.8s. View

ONDETTI M, Williams N, SABO E, Pluscec J, Weaver E, Kocy O . Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry. 1971; 10(22):4033-9. DOI: 10.1021/bi00798a004. View

ENGEL S, Schaeffer T, Waugh M, Rubin B . Effects of the nonapeptide SQ 20881 on blood pressure of rats with experimental renovascular hypertension. Proc Soc Exp Biol Med. 1973; 143(2):483-7. DOI: 10.3181/00379727-143-37348. View

Cheung H, Cushman D . Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca. Biochim Biophys Acta. 1973; 293(2):451-63. DOI: 10.1016/0005-2744(73)90352-5. View

Dorer F, Kahn J, LENTZ K, Levine M, SKEGGS L . Hydrolysis of bradykinin by angiotensin-converting enzyme. Circ Res. 1974; 34(6):824-7. DOI: 10.1161/01.res.34.6.824. View

Gavras H, Brunner H, LARAGH J, SEALEY J, Gavras I, Vukovich R . An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med. 1974; 291(16):817-21. DOI: 10.1056/NEJM197410172911603. View

Chiu A, Ryan J, Stewart J, Dorer F . Formation of angiotensin III by angiotensin-converting enzyme. Biochem J. 1976; 155(1):189-92. PMC: 1172816. DOI: 10.1042/bj1550189. View

10.

Case D, Wallace J, Keim H, Weber M, Drayer J, White R . Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Am J Med. 1976; 61(5):790-6. DOI: 10.1016/0002-9343(76)90160-1. View

11.

Case D, Wallace J, Keim H, Weber M, SEALEY J, LARAGH J . Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med. 1977; 296(12):641-6. DOI: 10.1056/NEJM197703242961201. View

12.

Ryan J, Chung A, Ammons C, Carlton M . A simple radioassay for angiotensin-converting enzyme. Biochem J. 1977; 167(2):501-4. PMC: 1183685. DOI: 10.1042/bj1670501. View

13.

Johnson J, Black W, Vukovich R, HATCH Jr F, Friedman B, Blackwell C . Treatment of patients with severe hypertension by inhibition of angiotensin-converting enzyme. Clin Sci Mol Med Suppl. 1975; 2:53s-56s. DOI: 10.1042/cs048053s. View

14.

Gavras H, Brunner H, LARAGH J, Gavras I, Vukovich R . The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertension. Clin Sci Mol Med Suppl. 1975; 2:57s-60s. DOI: 10.1042/cs048057s. View

15.

Perez G, Epstein M, Rietberg B, Loutzenhiser R . Metabolism of arginine by the isolated perfused rat kidney. Am J Physiol. 1978; 235(4):F376-80. DOI: 10.1152/ajprenal.1978.235.4.F376. View

16.

Ryan J, Chung A, Martin L, Ryan U . New substrates for the radioassay of angiotensin converting enzyme of endothelial cells in culture. Tissue Cell. 1978; 10(3):555-62. DOI: 10.1016/s0040-8166(16)30348-2. View

17.

Kenny A, Booth A . Microvilli: their ultrastructure, enzymology and molecular organization. Essays Biochem. 1978; 14:1-44. View

18.

Fisher G, Ryan J, Martin L, Pena G . Structure-activity relationships for kininase II inhibition by lower homologs of the bradykinin potentiating peptide BPP9a. Adv Exp Med Biol. 1979; 120B:651-63. View